Hisao Ogawa

Hisao Ogawa

Japan

Publications
  • Research Article
    Re-evaluation of Bleeding Events in the Japanese PRASFIT-Elective and PRASFIT-ACS Clinical Trials using the Bleeding Academic Research Consortium Criteria
    Author(s): Shunichi Miyazaki, Takaaki Isshiki, Takeshi Kimura, Hisao Ogawa, Hiroyoshi Yokoi, Masakatsu Nishikawa, Masato Nakamura, Yuko Tanaka, and Shigeru Saito, on behalf of the PRASFIT-ACS Investigators and PRASFIT-Elective Investigators Shunichi Miyazaki, Takaaki Isshiki, Takeshi Kimura, Hisao Ogawa, Hiroyoshi Yokoi, Masakatsu Nishikawa, Masato Nakamura, Yuko Tanaka, and Shigeru Saito, on behalf of the PRASFIT-ACS Investigators and PRASFIT-Elective Investigators

    Background: In 2011, the Bleeding Academic Research Consortium (BARC) criteria were published to standardize the assessment of bleeding events following PCI. However, the status of bleeding events as assessed using the BARC criteria is not established in Japan. The aim of this post-hoc analysis of the PRASFIT-ACS and PRASFIT-Elective trials was to re-classify the bleeding events from the Thrombolysis in Myocardial Infarction (TIMI) criteria into the BARC criteria. Methods: Bleeding events had previously been assessed in both trials using the TIMI criteria. In the post-hoc analysis, the BARC criteria were applied retrospectively to each category of bleeding. Results: In PRASFIT-ACS, the incidences of severe bleeds (combined type 3 or 5 bleeds according to BARC criteria) were 43/685 [6.3%] with prasugrel and 37/678 [5.5%] with clopidogrel [HR 1.071; 95% CI 0.668–1.667]. Types 3 or.. View More»
    DOI: 10.4172/2329-6607.1000162

    Abstract PDF